首页 | 本学科首页   官方微博 | 高级检索  
检索        

氟尿嘧啶缓释植入剂治疗卵巢恶性肿瘤近期疗效观察
引用本文:武红,高蜀君.氟尿嘧啶缓释植入剂治疗卵巢恶性肿瘤近期疗效观察[J].现代保健,2013(20):3-5.
作者姓名:武红  高蜀君
作者单位:[1]郑州人民医院,河南郑州450003 [2]上海复旦大学附属妇产科医院,河南郑州450003
摘    要:目的:探讨氟尿嘧啶(5-Fu)缓释植入剂治疗卵巢恶性肿瘤的临床疗效。方法:将90例卵巢恶性肿瘤患者分为对照组45例和观察组45例,比较两组近期疗效。结果:1年无进展生存率观察组高于对照组,差异有统计学意义(P〈0.05),而2、3年无进展生存率两组间比较差异无统计学意义(P〉0.05)。结论:术中即时植入5-Fu缓释植入剂可降低卵巢恶性肿瘤患者术后近期肿瘤的进展复发,提高治疗有效率。

关 键 词:氟尿嘧啶缓释植入剂  卵巢肿瘤  缓释化疗  间质化疗  腹腔化疗

Observation of the Curative Effect of Fluorouracil Sustained-release Implants in the Treatment of Malignant Tumor of Ovary
Authors:WU Hong  GAO Shu-jun
Institution:( The People's Hospital of Zhengzhou,Zhengzhou 450003,China)
Abstract:Objective:To investigate the clinical efficacy of fluorouracil(5-Fu)sustained-release implants in the treatment of malignant ovarian cancer.Method:90 cases of ovarian cancer patients were divided into the control group(45 cases)and the observation group(45 cases).The difference between the two groups were compared various indicators of the short-term effect.Result:One year progression-free survival rate of the observation group was higher than the control group,the difference was statistically significant between the groups( P〈0.05),and two,three-year progression-free survival between the two groups showed no significant difference( P〈0.05).Conclusion:Intraoperative immediate implantation of 5-Fu release implants may reduce ovarian malignancies in patients with postoperative recurrence of the recent progress of the tumor,to improve the treatment efficiency.
Keywords:Fluorouracil sustained release implant  Ovarian tumors  Sustained-release chemotherapy  Interstitial chemotherapy  Intraperitoneal chemotherapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号